Toggle Main Menu Toggle Search

Open Access padlockePrints

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies

Lookup NU author(s): Professor Tim Goodship, Professor Neil SheerinORCiD



This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Publication metadata

Author(s): Licht C, Greenbaum LA, Muus P, Babu S, Bedrosian CL, Cohen D, Delmas Y, Douglas K, Furman R, Gaber O, Goodship T, Herthelius M, Hourmant M, Legendre C, Remuzzi G, Sheerin N, Trivelli A, Loirat C

Publication type: Article

Publication status: Published

Journal: Kidney International

Year: 2015

Volume: 87

Pages: 1061-1073

Print publication date: 01/05/2015

Online publication date: 04/02/2015

Acceptance date: 30/10/2014

Date deposited: 26/01/2015

ISSN (print): 0085-2538

ISSN (electronic): 1523-1755

Publisher: Nature Publishing Group


DOI: 10.1038/ki.2014.423


Altmetrics provided by Altmetric


Funder referenceFunder name
Alexion Pharmaceuticals
UL1TR000454National Center for Advancing Translational Sciences of the National Institutes of Health